{"id":"https://openalex.org/W2885742011","doi":"https://doi.org/10.1158/1538-7445.am2018-3877","title":"Abstract 3877: MPL-5821, a macrophage targeted ESMTM p38 MAPK inhibitor, inhibits the production of TLR agonist induced IL-10 whilst sparing T-cell functionality","display_name":"Abstract 3877: MPL-5821, a macrophage targeted ESMTM p38 MAPK inhibitor, inhibits the production of TLR agonist induced IL-10 whilst sparing T-cell functionality","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2885742011","doi":"https://doi.org/10.1158/1538-7445.am2018-3877","mag":"2885742011"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-3877","doi":"https://doi.org/10.1158/1538-7445.am2018-3877","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3877","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David Moffat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Moffat","raw_affiliation_strings":["1Macrophage Pharma, Windsor, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Macrophage Pharma, Windsor, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108422031","display_name":"Martin Perry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Perry","raw_affiliation_strings":["1Macrophage Pharma, Windsor, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Macrophage Pharma, Windsor, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062581256","display_name":"Anne Marijne Heeren","orcid":"https://orcid.org/0000-0002-4158-6058","observed_orcids":["https://orcid.org/0000-0002-4158-6058"]},"institutions":[{"id":"https://openalex.org/I4210138709","display_name":"Centrum voor Gynaecologische Oncologie Amsterdam","ror":"https://ror.org/03sxzz606","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210138709"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A. Marijne Heeren","raw_affiliation_strings":["2Center Gynecological Oncology Amsterdam (CGOA), Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Center Gynecological Oncology Amsterdam (CGOA), Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I4210138709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053105927","display_name":"Tanja D. de Gruijl","orcid":"https://orcid.org/0000-0003-1464-8978","observed_orcids":["https://orcid.org/0000-0003-1464-8978"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tanja D. de Gruijl","raw_affiliation_strings":["3VU University Medical Center, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3VU University Medical Center, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025427398","display_name":"Justyna Rzepecka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justyna Rzepecka","raw_affiliation_strings":["4Aquila BioMedical Ltd, Edinburgh, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aquila BioMedical Ltd, Edinburgh, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089020385","display_name":"Lucia Janicova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucia Janicova","raw_affiliation_strings":["4Aquila BioMedical Ltd, Edinburgh, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aquila BioMedical Ltd, Edinburgh, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049803569","display_name":"Anastasia Nika","orcid":"https://orcid.org/0000-0003-1031-1753","observed_orcids":["https://orcid.org/0000-0003-1031-1753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anastasia Nika","raw_affiliation_strings":["4Aquila BioMedical Ltd, Edinburgh, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aquila BioMedical Ltd, Edinburgh, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004272116","display_name":"Darryl G. Turner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darryl Turner","raw_affiliation_strings":["4Aquila BioMedical Ltd, Edinburgh, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aquila BioMedical Ltd, Edinburgh, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Clare Doris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clare Doris","raw_affiliation_strings":["4Aquila BioMedical Ltd, Edinburgh, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aquila BioMedical Ltd, Edinburgh, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011847273","display_name":"Claire Tebbutt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claire Tebbutt","raw_affiliation_strings":["5Domainex Ltd, Saffron Walden, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Domainex Ltd, Saffron Walden, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kathryn Chapman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathryn Chapman","raw_affiliation_strings":["5Domainex Ltd, Saffron Walden, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Domainex Ltd, Saffron Walden, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017881708","display_name":"Gary K. Newton","orcid":"https://orcid.org/0000-0002-2721-0089","observed_orcids":["https://orcid.org/0000-0002-2721-0089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary Newton","raw_affiliation_strings":["5Domainex Ltd, Saffron Walden, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Domainex Ltd, Saffron Walden, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113798607","display_name":"Stephen M. Anderton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Anderton","raw_affiliation_strings":["4Aquila BioMedical Ltd, Edinburgh, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Aquila BioMedical Ltd, Edinburgh, United Kingdom;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"3877","last_page":"3877"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.10779999941587448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.06120000034570694,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p38-mapk-inhibitor","display_name":"p38 MAPK inhibitor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/macrophage-targeting","display_name":"macrophage targeting","score":0.8410000205039978},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.8709999918937683},{"id":"https://openalex.org/keywords/toll-like-receptor-agonists","display_name":"TLR agonists","score":0.8550000190734863},{"id":"https://openalex.org/keywords/r848","display_name":"R848","score":0.9200000166893005},{"id":"https://openalex.org/keywords/il-12p70","display_name":"IL-12p70","score":0.9309999942779541},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8050000071525574},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.609000027179718},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/tlr7-8","display_name":"TLR7/8","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5125762820243835},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5116622447967529},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5023407936096191},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4824267327785492},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4821174144744873},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.47368693351745605},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4483022093772888},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43385568261146545},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.40277332067489624},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38404256105422974},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35872089862823486},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.23682138323783875},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19454649090766907},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-3877","doi":"https://doi.org/10.1158/1538-7445.am2018-3877","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3877","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8600000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2914484697","https://openalex.org/W2602761843","https://openalex.org/W4200022043","https://openalex.org/W2112727616","https://openalex.org/W1820832512","https://openalex.org/W2884525857","https://openalex.org/W4322720888","https://openalex.org/W4296613612","https://openalex.org/W3193904228","https://openalex.org/W4292999066"],"abstract_inverted_index":{"Abstract":[0],"Compensatory":[1],"release":[2],"of":[3,28,58,65,70,85,118,133,148,173,178,196,364,385,393,400,407,419,428,476,488],"immunosuppressive":[4],"cytokines,":[5],"such":[6],"as":[7,19,150,281],"IL-10,":[8,420],"by":[9,81,283,324,337,345,374],"macrophages":[10],"present":[11,123],"in":[12,109,140,225,230,288,304,361,424,431],"the":[13,45,59,68,146,174,179,186,193,263,276,315,331,333,349,362,412,426,432,474,489],"tumor":[14,254,311,316],"microenvironment":[15],"has":[16,78,411],"been":[17,79],"implicated":[18,423],"a":[20,26,62,291,318,466],"mechanism":[21],"for":[22,189,268,330,353,492],"adaptive":[23],"resistance":[24],"to":[25,55,111,152,157,170,184,198,214,222,290,403,414],"number":[27],"immunotherapies.":[29],"Our":[30],"drug":[31],"discovery":[32],"effort":[33],"utilises":[34],"Esterase":[35],"Motif":[36],"TechnologyTM":[37],"(ESMTM)":[38],"which":[39,66,97,421],"selectively":[40],"targets":[41],"myelomonocytic":[42],"cells":[43,334],"sparing":[44,172,482],"concomitant":[46,391],"lymphocyte":[47,119,207],"anti-tumor":[48],"immune":[49,60],"response.":[50],"TLR":[51,161,228,264,359,386,416,429,477],"agonists":[52,229,430],"are":[53],"known":[54],"be":[56],"stimulators":[57],"response,":[61],"key":[63],"component":[64],"is":[67,91,422],"production":[69,203,280,368,475],"myeloid":[71],"cell":[72,247,305,320,340,350],"IL-12p70.":[73],"However,":[74],"their":[75,82],"therapeutic":[76],"potential":[77,413],"limited":[80],"accompanying":[83],"induction":[84,418],"IL-10":[86,101,202,279,389,480],"and":[87,108,138,236,241,258,270,287,312,326,329,348],"other":[88,180],"factors.":[89],"MPL-5821":[90,126,224,261,273,303,380],"an":[92],"ESMTM":[93,401,469],"p38":[94,113,153,293,408,470],"MAPK":[95,114,409,471],"inhibitor":[96,295],"not":[98,158],"only":[99,159],"inhibits":[100,473],"but":[102,165],"also":[103,166,297],"enhances":[104],"LPS":[105,200],"stimulated":[106],"IL-12p70":[107],"contrast":[110,125,289],"conventional":[112,292],"inhibitors":[115,132,410],"provides":[116],"enhancement":[117,392],"IFN\u03b3":[120,168,208,299,394],"production.":[121,300,395],"The":[122,339],"studies":[124,213],"with":[127,227,260,356,390],"multiple":[128],"non-targeted":[129],"agents,":[130],"including":[131],"HDAC,":[134],"JAK,":[135],"PI3K,":[136],"MEK":[137],"CSF-1R,":[139],"human":[141,215,309],"PBMC":[142],"assays.":[143],"These":[144],"demonstrated":[145],"benefit":[147],"ESMTM-targeting":[149],"applied":[151],"MAP":[154,294],"kinase":[155],"inhibition":[156,384],"inhibit":[160,199,415],"agonist":[162,266,360,387,417,478],"induced":[163,201,278,388,479],"immunosuppression":[164],"enhance":[167],"due":[169],"its":[171],"myeloid-lymphocyte":[175],"axis.":[176],"None":[177],"modalities":[181],"were":[182,335,342],"able":[183],"achieve":[185],"effects":[187],"observed":[188],"MPL-5821.":[190],"Having":[191],"established":[192],"unique":[194],"ability":[195],"MPL-5281":[197],"whilst":[204,481],"still":[205],"maintaining":[206],"production,":[209],"we":[210],"extended":[211],"our":[212],"cancer":[216,243,253],"ex":[217,231],"vivo":[218,232],"models.":[219],"We":[220,301,396],"chose":[221],"evaluate":[223],"combination":[226],"assays":[233],"using":[234],"tissue":[235],"ascites":[237,332],"derived":[238],"from":[239,251,308],"ovarian":[240,310],"cervical":[242,252],"patients.":[244],"A":[245],"single":[246,319],"suspension":[248],"was":[249,322,369],"prepared":[250,307,323],"draining":[255],"lymph":[256],"nodes":[257],"incubated":[259],"+/-":[262],"7/8":[265],"R848":[267,277],"24":[269],"48":[271],"hours.":[272],"potently":[274],"inhibited":[275],"measured":[282,370],"Cytometric":[284],"Bead":[285],"Array":[286],"LY2228820":[296],"enhanced":[298],"studied":[302],"suspensions":[306],"ascites.":[313],"For":[314],"sample,":[317],"homogenate":[321],"mechanical":[325],"enzymatic":[327],"digestion":[328],"isolated":[336],"centrifugation.":[338],"populations":[341],"then":[343],"analysed":[344],"flow":[346],"cytometry":[347],"preparation":[351],"cultured":[352],"72":[354,372],"hours":[355,373],"anti-CD3":[357],"or":[358,376],"presence":[363],"test":[365],"compound.":[366],"Cytokine":[367],"after":[371],"ELISA":[375],"Luminex":[377],"bead":[378],"array.":[379],"again":[381],"showed":[382],"potent":[383],"conclude":[397],"that":[398],"application":[399],"technology":[402],"macrophage":[404,467],"selective":[405],"delivery":[406],"limiting":[425],"performance":[427],"clinic.":[433],"Citation":[434],"Format:":[435],"David":[436],"Moffat,":[437],"Martin":[438],"Perry,":[439],"A.":[440],"Marijne":[441],"Heeren,":[442],"Tanja":[443],"D.":[444],"de":[445],"Gruijl,":[446],"Justyna":[447],"Rzepecka,":[448],"Lucia":[449],"Janicova,":[450],"Anastasia":[451],"Nika,":[452],"Darryl":[453],"Turner,":[454],"Clare":[455],"Doris,":[456],"Claire":[457],"Tebbutt,":[458],"Kathryn":[459],"Chapman,":[460],"Gary":[461],"Newton,":[462],"Stephen":[463],"Anderton.":[464],"MPL-5821,":[465],"targeted":[468],"inhibitor,":[472],"T-cell":[483],"functionality":[484],"[abstract].":[485],"In:":[486],"Proceedings":[487],"American":[490],"Association":[491],"Cancer":[493,506],"Research":[494],"Annual":[495],"Meeting":[496],"2018;":[497],"2018":[498],"Apr":[499],"14-18;":[500],"Chicago,":[501],"IL.":[502],"Philadelphia":[503],"(PA):":[504],"AACR;":[505],"Res":[507],"2018;78(13":[508],"Suppl):Abstract":[509],"nr":[510],"3877.":[511]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}